Nearly a decade ago, an article was published with the title,"The world's most valuable resource is no longer oil, but data." That statement feels more relevant than ever now. In healthcare, data can drivebetter outcomes, smarter decisions, and cost savings, but only if we understandwhat it's actually telling us.

‍

Construction is in full swing this time of year and jobsites are getting busier every week. Crews are trying to stay on schedule while multiple different trades work in the same area.

Scaffolding shows up on almost every job site at some point. It's how crews get to the heights they'd otherwise have no safe way to reach.

How group captives are giving mid-market employers a third option between fully insured stability and self-funded volatility.

‍

North Carolina has taken a decisive step that could reshape the legal landscape for businesses nationwide. With the passage of House Bill 315, the state became the first in the country to ban third-party litigation investment — a fast-growing practice where outside investors fund lawsuits in exchange for a portion of the outcome.

‍

While this may sound like a niche legal reform, its implications are far-reaching — especially for trucking and transportation companies that have been on the front lines of rising litigation pressure.

‍

The U.S. Supreme Court issued a ruling in Montgomery v.Caribe Transport II, LLC that changes the liability landscape for freightbrokers nationwide. Below I’ve outlined the key takeaways and where to focusnext.

‍

On January 20, 2026, the U.S. Occupational Safety and Health Administration (OSHA) issued a formal interpretation addressing whether injuries caused by personal rechargeable lithium-ion batteries brought into the workplace must be recorded on the OSHA 300 Log. There are several key takeaways listed below:

Around 90% of companies in the construction industry employ 20 or fewer employees. This can make it very difficult to ensure that employees are receiving the proper safety training, since resources like time and money are often limited. Those tasked with safety compliance usually have other responsibilities, making it hard for them to dedicate the necessary time to safety. However, one easy step that can be taken is the implementation of toolbox talks

The pharmaceutical industry is entering a major transformation driven by two federal pricing reforms: the Inflation Reduction Act (IRA) and new Most Favored Nation (MFN) pricing initiatives signed in 2025. These changes will allow Medicare to negotiate lower prices on many high‑cost medications and tie U.S. drug prices more closely to those in other developed countries. As manufacturers face reduced margins and increasing pressure for price transparency, many are turning to a new strategy: selling medications directly to consumers at cash prices. While this trend is largely aimed at patients, it’s poised to have ripple effects on employer-sponsored health plans.